Senolytics such as Navitoclax and Dasatinib/Quercetin selectively eliminated VIS cells, mitigated COVID-19-reminiscent lung disease and reduced inflammation in SARS-CoV-2-driven hamster and mouse models.
link
Virus-induced senescence is driver and therapeutic target in COVID-19
American Buddhist Net 